Verition Fund Management »

Akero Therapeutics shares owned by Verition Fund Management

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Verition Fund Management from 13F filings

Historical chart of Verition Fund Management investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Verition Fund Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $217k 9.3k 23.46
2023-03-31 $205k 5.4k 38.26